Logo image of IMAX

IMAX CORP (IMAX) Stock Fundamental Analysis

NYSE:IMAX - New York Stock Exchange, Inc. - CA45245E1097 - Common Stock - Currency: USD

26.99  -0.12 (-0.44%)

After market: 26.99 0 (0%)

Fundamental Rating

5

Taking everything into account, IMAX scores 5 out of 10 in our fundamental rating. IMAX was compared to 71 industry peers in the Entertainment industry. Both the profitability and the financial health of IMAX get a neutral evaluation. Nothing too spectacular is happening here. IMAX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IMAX was profitable.
IMAX had a positive operating cash flow in the past year.
In multiple years IMAX reported negative net income over the last 5 years.
Of the past 5 years IMAX 4 years had a positive operating cash flow.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

IMAX has a Return On Assets of 2.96%. This is in the better half of the industry: IMAX outperforms 77.46% of its industry peers.
The Return On Equity of IMAX (8.38%) is better than 80.28% of its industry peers.
IMAX has a Return On Invested Capital of 6.11%. This is in the better half of the industry: IMAX outperforms 74.65% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IMAX is significantly below the industry average of 23.28%.
The last Return On Invested Capital (6.11%) for IMAX is above the 3 year average (4.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.96%
ROE 8.38%
ROIC 6.11%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

IMAX's Profit Margin of 6.98% is amongst the best of the industry. IMAX outperforms 83.10% of its industry peers.
In the last couple of years the Profit Margin of IMAX has declined.
With an excellent Operating Margin value of 14.59%, IMAX belongs to the best of the industry, outperforming 85.92% of the companies in the same industry.
In the last couple of years the Operating Margin of IMAX has declined.
IMAX has a Gross Margin of 54.62%. This is in the better half of the industry: IMAX outperforms 60.56% of its industry peers.
IMAX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.59%
PM (TTM) 6.98%
GM 54.62%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

5

2. Health

2.1 Basic Checks

IMAX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
IMAX has less shares outstanding than it did 1 year ago.
IMAX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, IMAX has a worse debt to assets ratio.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 1.89 indicates that IMAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
IMAX has a Altman-Z score of 1.89. This is in the better half of the industry: IMAX outperforms 63.38% of its industry peers.
The Debt to FCF ratio of IMAX is 3.90, which is a good value as it means it would take IMAX, 3.90 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IMAX (3.90) is better than 73.24% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that IMAX is somewhat dependend on debt financing.
IMAX has a Debt to Equity ratio (0.77) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 3.9
Altman-Z 1.89
ROIC/WACC0.89
WACC6.84%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.50 indicates that IMAX should not have too much problems paying its short term obligations.
IMAX's Current ratio of 1.50 is fine compared to the rest of the industry. IMAX outperforms 71.83% of its industry peers.
A Quick Ratio of 1.31 indicates that IMAX should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.31, IMAX is in the better half of the industry, outperforming 66.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.31
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

The earnings per share for IMAX have decreased by 0.00% in the last year.
The Earnings Per Share has been decreasing by -2.17% on average over the past years.
IMAX shows a decrease in Revenue. In the last year, the revenue decreased by -1.99%.
IMAX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.30% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%-13.33%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%9.53%

3.2 Future

Based on estimates for the next years, IMAX will show a very strong growth in Earnings Per Share. The EPS will grow by 27.68% on average per year.
IMAX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.11% yearly.
EPS Next Y21.71%
EPS Next 2Y19.4%
EPS Next 3Y15.83%
EPS Next 5Y27.68%
Revenue Next Year11.63%
Revenue Next 2Y8.39%
Revenue Next 3Y7.11%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.02, the valuation of IMAX can be described as expensive.
IMAX's Price/Earnings ratio is a bit cheaper when compared to the industry. IMAX is cheaper than 76.06% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.03. IMAX is around the same levels.
IMAX is valuated rather expensively with a Price/Forward Earnings ratio of 19.93.
Based on the Price/Forward Earnings ratio, IMAX is valued a bit cheaper than 78.87% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IMAX to the average of the S&P500 Index (21.94), we can say IMAX is valued inline with the index average.
Industry RankSector Rank
PE 29.02
Fwd PE 19.93
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IMAX is valued a bit cheaper than 71.83% of the companies in the same industry.
IMAX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IMAX is cheaper than 76.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.23
EV/EBITDA 14.15
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

IMAX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of IMAX may justify a higher PE ratio.
IMAX's earnings are expected to grow with 15.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.34
PEG (5Y)N/A
EPS Next 2Y19.4%
EPS Next 3Y15.83%

0

5. Dividend

5.1 Amount

IMAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IMAX CORP

NYSE:IMAX (5/21/2025, 8:06:09 PM)

After market: 26.99 0 (0%)

26.99

-0.12 (-0.44%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)04-23 2025-04-23/amc
Earnings (Next)07-22 2025-07-22
Inst Owners90.81%
Inst Owner Change1.79%
Ins Owners19.43%
Ins Owner Change1.65%
Market Cap1.45B
Analysts80
Price Target31.21 (15.64%)
Short Float %13.83%
Short Ratio5.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.74%
Min EPS beat(2)-6.42%
Max EPS beat(2)11.91%
EPS beat(4)3
Avg EPS beat(4)49.12%
Min EPS beat(4)-6.42%
Max EPS beat(4)138.86%
EPS beat(8)7
Avg EPS beat(8)74.71%
EPS beat(12)8
Avg EPS beat(12)23.52%
EPS beat(16)11
Avg EPS beat(16)18.84%
Revenue beat(2)1
Avg Revenue beat(2)-5.16%
Min Revenue beat(2)-11.37%
Max Revenue beat(2)1.04%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)14.74%
Revenue beat(8)4
Avg Revenue beat(8)1.2%
Revenue beat(12)6
Avg Revenue beat(12)1.21%
Revenue beat(16)8
Avg Revenue beat(16)3.18%
PT rev (1m)0%
PT rev (3m)10.36%
EPS NQ rev (1m)-5.5%
EPS NQ rev (3m)-4.56%
EPS NY rev (1m)-9.88%
EPS NY rev (3m)-6.75%
Revenue NQ rev (1m)-0.68%
Revenue NQ rev (3m)-4.15%
Revenue NY rev (1m)-0.54%
Revenue NY rev (3m)-2.48%
Valuation
Industry RankSector Rank
PE 29.02
Fwd PE 19.93
P/S 4.03
P/FCF 20.23
P/OCF 16.34
P/B 4.84
P/tB 7.22
EV/EBITDA 14.15
EPS(TTM)0.93
EY3.45%
EPS(NY)1.35
Fwd EY5.02%
FCF(TTM)1.33
FCFY4.94%
OCF(TTM)1.65
OCFY6.12%
SpS6.69
BVpS5.57
TBVpS3.74
PEG (NY)1.34
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.96%
ROE 8.38%
ROCE 7.71%
ROIC 6.11%
ROICexc 7.12%
ROICexgc 10.94%
OM 14.59%
PM (TTM) 6.98%
GM 54.62%
FCFM 19.93%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexcg growth 3Y113.18%
ROICexcg growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 3.9
Debt/EBITDA 1.99
Cap/Depr 27.12%
Cap/Sales 4.74%
Interest Coverage 250
Cash Conversion 76.92%
Profit Quality 285.52%
Current Ratio 1.5
Quick Ratio 1.31
Altman-Z 1.89
F-Score4
WACC6.84%
ROIC/WACC0.89
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%-13.33%
EPS Next Y21.71%
EPS Next 2Y19.4%
EPS Next 3Y15.83%
EPS Next 5Y27.68%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%9.53%
Revenue Next Year11.63%
Revenue Next 2Y8.39%
Revenue Next 3Y7.11%
Revenue Next 5YN/A
EBIT growth 1Y-4.8%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year216.7%
EBIT Next 3Y44.41%
EBIT Next 5Y37.72%
FCF growth 1Y149.83%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y109.83%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%